In this blog post, we will compare the types and characteristics of stem cells and examine both the scientific value and ethical issues surrounding embryonic stem cell research.
What Are Stem Cells?
A stem cell, as the name suggests, is an “undifferentiated cell”—a cell with the potential to differentiate into various types of cells. Because they can develop into most types of human body tissue, they hold great medical promise. Stem cells can be broadly categorized into three types: embryonic stem cells, adult stem cells, and induced pluripotent stem cells (iPS cells). Among these, embryonic stem cells are receiving the most attention. While they are expected to have high therapeutic efficacy, they are at the center of much controversy due to the ethical issues they raise. In this article, we will compare the characteristics of these three types of stem cells and take an in-depth look at the scientific value, potential, and ethical issues surrounding embryonic stem cells in particular.
Comparison of the Three Types of Stem Cells
Embryonic stem cells are derived from fertilized eggs (zygotes) formed by the union of sperm and egg, and possess “totipotency,” meaning they can differentiate into almost any type of cell in the human body. While they cause minimal immune rejection upon transplantation and have a wide range of applications, they present ethical challenges because controlling cell differentiation is difficult, there is a risk of tumor development, and the process requires the destruction of embryos. For example, in vitro fertilization, the development of artificial wombs, and research aimed at generating sperm and eggs from skin cells are topics directly linked to the creation of life. While such efforts, if successful, could greatly help resolve infertility issues, there is also the possibility that these technologies could be misused for commercial purposes or criminal activities, leading to ongoing controversy. This is why opposition grows louder as technology advances.
Adult stem cells are stem cells found in small quantities within already developed body tissues, such as bone marrow, skin, and olfactory nerves. They have a high degree of differentiation stability, making them less likely to develop into cancer cells, and some are already being used in clinical applications. Above all, their major advantage is that they pose almost no ethical issues since they do not involve the destruction of fertilized eggs. However, they also have drawbacks, such as a limited number of cells that can be obtained, restricted differentiation capabilities, and the potential for immune rejection upon transplantation.
Meanwhile, induced pluripotent stem cells (iPS cells) are created by introducing genes into adult cells to reprogram them to behave like embryonic stem cells. They gained attention after Dr. Shinya Yamanaka’s research team in Japan achieved success in mouse experiments, and global interest intensified when they were awarded the 2012 Nobel Prize in Physiology or Medicine. iPS cells have the advantage of causing almost no immune rejection because they can be created from the patient’s own cells, and they also carry relatively fewer ethical concerns since they do not destroy embryos. Currently, their potential applications are being explored in various fields, including treatment for burn patients, organ damage, and spinal cord injuries.
Expectations and Potential Applications of Stem Cells
The fields where iPS cells are receiving particular attention are new drug development and regenerative medicine. By differentiating and culturing iPS cells derived from a patient’s skin cells into specific cell types needed for treatment and then transplanting them back into the patient, it is expected that natural tissue restoration and organ regeneration will be possible. Since the patient’s own cells are used in this process, there is virtually no immune rejection, making it an alternative that overcomes a major limitation of existing treatments.
Furthermore, it holds high potential for treating congenital disorders and intractable diseases. For example, this approach involves creating iPS cells from the cells of a patient with a genetic disorder, repairing the damaged gene, and reintroducing the cells into the body to restore function.
This could open new avenues for treating various diseases, such as hemophilia, congenital immunodeficiency, and Parkinson’s disease.
Embryonic Stem Cells: Scientific Value and Ethical Dilemmas
Embryonic stem cells are obtained by isolating the inner cell mass from a blastocyst, which develops 4–5 days after fertilization. Obtaining these cells requires the use of embryos, which can be sourced from surplus embryos remaining after fertility treatments or from embryos cloned via somatic cell nuclear transfer. Consequently, research using human embryos is strictly regulated legally and ethically in various countries, and South Korea also stipulates research subjects, methods, and permissible scope through laws such as the “Act on Bioethics and Safety.”
Stem cell research has always been accompanied by bioethical issues alongside its scientific potential. While it clearly offers hope to patients in desperate need of treatment, the question of whether it is truly justifiable to conduct research at the cost of destroying embryos—the foundation of human life—remains valid. Regardless of the definition of whether an embryo is a living being, it deserves respect simply because it represents the fundamental stage of life. Research that challenges the very essence of human life requires caution; even if it slows down progress, it must be accompanied by ethical standards and philosophical deliberation.
This stance should not be dismissed as merely the words of someone who says, “My family doesn’t have an incurable disease.” Compared to the pace of advancement in life sciences, legal and ethical standards are often still inadequate, and in some countries, human rights violations occur for economic reasons. Unethical research or data manipulation to gain an edge in academic competition must never occur, and we must not forget that the ultimate value pursued by academia lies in human well-being.
Conclusion: For the Harmonious Development of Science and Life
If the processes of egg donation or embryo acquisition required for stem cell research are conducted transparently and fairly, there is no reason to oppose them in and of themselves. However, issues such as the possibility that women in impoverished nations may be left in a legal gray area regarding their human rights, and the lack of legal protection against disease transmission or side effects, must be addressed.
While the advancement of science for the treatment of diseases is undoubtedly an important task, its starting point must always be the dignity of human life. Following the successful isolation of embryonic stem cells, countries began enacting laws in response to concerns about side effects and ethical issues, and most nations strictly prohibit reproductive cloning for human reproduction. On the other hand, positions on therapeutic cloning vary by country, with the United Kingdom allowing it relatively broadly.
Stem cell research is not merely a matter of life sciences. This field is a complex domain where various disciplines—including cutting-edge technology, human rights, law, and ethics—must intersect and collaborate. Therefore, experts from each field must communicate closely to establish a framework and develop standards that society as a whole can accept.
When we look at the issue broadly, without bias, truths and standards we may have overlooked will guide scientific research in the right direction. Remembering that true progress stems not from “speed” but from “depth,” I hope that stem cell research will also become a step toward the happiness of all humanity.
